Canopy Growth Corporation (CGC) Financials
CGC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.0 billion | 614.5 million |
2023-09-30 | 1.2 billion | 676.0 million |
2023-06-30 | 1.7 billion | 1.0 billion |
2023-03-31 | 1.8 billion | 1.2 billion |
CGC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -24.9 million | 2.8 million |
2023-09-30 | -58.7 million | 1.9 million |
2023-06-30 | -114.1 million | 2.9 million |
2023-03-31 | -105.6 million | 7.0 million |
CGC Net Income
No data available :(
CGC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 140.4 million | - | 61.2 million |
2023-09-30 | 198.9 million | - | 61.8 million |
2023-06-30 | 431.4 million | - | 67.9 million |
2023-03-31 | 578.5 million | - | 80.8 million |
CGC Shares Outstanding
CGC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 359633 | 988426 | 19.9 million | 13.8 million |
2023-09-30 | 829255 | 813067 | 16.0 million | 14.4 million |
2023-06-30 | 1.7 million | 1.0 million | 22.2 million | 35.5 million |
2023-03-31 | 2.3 million | 3.2 million | 80.6 million | 46.3 million |
CGC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 59.2 million | 37.9 million |
2023-09-30 | 60.4 million | 43.2 million |
2023-06-30 | 82.1 million | 77.6 million |
2023-03-31 | 64.7 million | 131.6 million |
CGC
Price: $9.72
52 week price:
Earnings Per Share: -15.56 USD
P/E Ratio: -0.27
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 11.1 million
Market Capitalization: 712.2 million